Women between 40 and 60 years old are the focus of new national guidelines aimed at preventing unhealthy weight gain that can lead to serious illness. The study review paper and clinical guidelines are published in the Annals of Internal Medicine.
Multiple cases of monkeypox have surfaced in Europe and the U.S. that do not appear to be linked to travel, causing concern among the medical community that this infectious disease is spreading through sexual contact or other close interactions.
The Arizona COVID-19 Genomics Union, led by Paul Keim and others throughout the state, is positioning Arizona to play a role in the planned U.S. Pathogen Genomics Centers of Excellence, a national network funded by the U.S. Centers for Disease Control and Prevention that would expand and deepen infectious disease collaborations between U.S. public health agencies and universities.
The American Cleaning Institute (ACI) launched a new website for the Healthy Schools, Healthy People initiative, a joint effort of ACI and the Centers for Disease Control and Prevention (CDC) to promote hand hygiene and cleaning practices as a means to prevent the spread of infectious disease in schools and reduce illness-related absenteeism.
UCLA researchers are seeking participants for an innovative study examining the impact of COVID-19 on survivors who continue battling health issues long after they were infected and thought to have recovered, known informally as “long COVID” and “longhaulers.”
The Association of American Cancer Institutes (AACI) commends the U.S. Food and Drug Administration (FDA) for its swift action to grant Emergency Use Authorization (EUA) to Pfizer’s COVID-19 vaccine.
The American College of Rheumatology (ACR) was recently awarded a $7M grant to reduce inequities in symptom recognition, care and disease management of systemic lupus erythematosus (lupus). The grant, which will be led by the ACR’s Collaborative Initiatives (COIN) department, begins on Sept. 30.
.ROCKVILLE, MD – As concern continues to grow concerning the novel coronavirus, COVID-19, so does the opportunity for misinformation to spread as the public searches for reliable information on infection and means of protection.
One-third of Americans do not have access to paid sick leave. Only the U.S. and Japan do not mandate a national sick leave benefit. Currently, seven states in the U.S. mandate that employers provide paid sick leave benefits. Given the latest information from the U.S. CDC regarding the potential impact that the coronavirus could have on the nation, researchers urge that it is critical to consider the role paid sick leave has in stopping the spread of a contagious virus.
UCLA Fielding School of Public Health experts available for media covering novel coronavirus (COVID-19) include: Dr. Robert J. Kim-Farley serves as professor-in-residence of epidemiology and community health sciences at the Fielding School. His previous roles include director of the Division of…
Every day nearly 200 people die from an overdose of drugs or from alcohol poisoning, with opioids responsible for the majority. Recognizing the signs and knowing how to respond to medical emergencies, including carrying and administering naloxone in cases of opioid overdose, can save lives says the ASA.
Faculty experts at UCLA’s Fielding School of Public Health with significant scientific and public health expertise with regards to infectious diseases, including coronavirus, include: Anne Rimoin, Phd, MPH, an epidemiologist with more than 18 years of experience working internationally and…
The spending bill passed today is a welcome step forward. Allocations in the bill will strengthen public health and research efforts during the year ahead and will provide critical support for important goals. At the same time, the legislation in its final form also brings inadequate responses to current and urgent challenges with the potential for long-term and costly consequences.
H.R. 3, the Elijah E. Cummings Lower Drug Costs Now Act passed by the House of Representatives today introduces critically needed and significant steps to reduce costs and improve access to life-saving therapies for conditions including HIV and hepatitis C. Importantly, the legislation also brings essential resources to combat antibiotic resistance, find and develop new infection fighting drugs and bring them to market. The balanced approach of this legislation will serve patients and public health.